Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

678 IndexPPain managementadjuvant analgesics, 389analgesic administration route, 384assessment for, 375–377, 391assessment of aberrant drug-relatedbehaviors in, 371–373categories of patients, 374–375clinical concerns, 367–368, 386–387,391definition of addiction in, 370–371dosing considerations, 384–385drug dependence and, 369–370drug selection for, 380–384drug tolerance in, 368–369nonsteroidal anti-inflammatory drugsfor, 387–389opioid therapy, 368, 374–375, 378–387patient selection, 378–380in people with substance abusedisorders, 373–374, 376prevalence of chronic pain, 367side effects of opioid therapy, 385–386strategies, 377–378Pancreatitis, alcohol-induced, 91Panic disorderalcohol use and, 80, 99benzodiazepine discontinuation inpeople with, 236–237cocaine use and, 194Paroxetinefor kleptomania, 315for pathological gambling, 309Partial agonist drugs, 589Patterns and prevalence of use, 20–21among adolescents, 559, 560–561among elderly, 396, 397–399associated personality profiles, 256–257benzodiazepines, 221club drugs and circuit parties, 260–262cocaine, 184–186gender differences, 438identifying nonmedical use, 221–222methamphetamine, 206physicians, 350polysubstance, 248–253racial/ethnic differences, 322–323,324–326, 328–331, 332–333sedative/hypnotic drugs, 220–221in workplace, 341Pemoline, 290, 575, 576Pentazocine, 113Pentobarbital, 224Perceptual field dependence, 40Performance-enhancing drugs, 348, 352Personal Experience Inventory, 47Personality disordersalcohol abuse and, 81–82cocaine use and, 195–196comorbid substance use disorder, 253–254co-occurring pathological gambling,308Personality traitsadolescent substance abuse risk, 562–563substance use disorders and, 255–257Pharmacotherapyabuse potential of psychoactiveagents, 290–291adherence, 642–643adolescents with psychiatriccomorbidity, 574–576alcohol abuse treatment, 644–646for alcoholism in elderly persons, 404–405alcohol relapse prevention, 593–595alcohol withdrawal, 591–593applications, 638behaviorally-oriented, 639–640for benzodiazepine withdrawal, 596for cocaine abuse, 603–606comorbidity considerations, 286–292,606, 640for compulsive buying, 316–317for detoxification, 639in dialectical behavior therapy, 633–634drug interactions, 602–603effectiveness, 643–644